Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-10

FDA Approved: LATANOPROST — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for latanoprost by Aurobindo Pharma Limited, approving a generic ophthalmic latanoprost product. It is indicated to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Latanoprost (Latanoprost)

Snippet

SUPPL AP for LATANOPROST (LATANOPROST)